Elimination of Osteosarcoma by Necroptosis with Graphene Oxide-Associated Anti-HER2 Antibodies
出版年份 2019 全文链接
标题
Elimination of Osteosarcoma by Necroptosis with Graphene Oxide-Associated Anti-HER2 Antibodies
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 18, Pages 4360
出版商
MDPI AG
发表日期
2019-09-06
DOI
10.3390/ijms20184360
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
- (2019) Ruiling Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Dissecting the functional role of microRNA 21 in osteosarcoma
- (2019) Durairaj Sekar et al. CANCER GENE THERAPY
- Pan-caspase inhibitors induce necroptosis via ROS-mediated activation of mixed lineage kinase domain-like protein and p38 in classically activated macrophages
- (2019) Atsushi Koike et al. EXPERIMENTAL CELL RESEARCH
- Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
- (2019) Zenan Wang et al. Frontiers in Immunology
- Association of anti-HER2 antibody with graphene oxide for curative treatment of osteosarcoma
- (2018) Lan Li et al. Nanomedicine-Nanotechnology Biology and Medicine
- Immunotherapy for osteosarcoma: Where do we go from here?
- (2018) Mary F. Wedekind et al. PEDIATRIC BLOOD & CANCER
- Proteasome inhibition blocks necroptosis by attenuating death complex aggregation
- (2018) Mohammad Ali et al. Cell Death & Disease
- Necroptosis occurs in osteoblasts during tumor necrosis factor-α stimulation and caspase-8 inhibition
- (2018) Guan Shi et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs
- (2017) Julian Andreev et al. MOLECULAR CANCER THERAPEUTICS
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Spontaneous Protein Adsorption on Graphene Oxide Nanosheets Allowing Efficient Intracellular Vaccine Protein Delivery
- (2016) Hui Li et al. ACS Applied Materials & Interfaces
- Graphene-based nanosheets for delivery of chemotherapeutics and biological drugs
- (2016) Gayong Shim et al. ADVANCED DRUG DELIVERY REVIEWS
- In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide
- (2016) Dongzhi Yang et al. BIOMATERIALS
- Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked
- (2016) Sabine Hannes et al. CANCER LETTERS
- Cancer therapy in the necroptosis era
- (2016) Z Su et al. CELL DEATH AND DIFFERENTIATION
- Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
- (2016) N. J. Mason et al. CLINICAL CANCER RESEARCH
- Mitochondrial calcium uptake underlies ROS generation during aminoglycoside-induced hair cell death
- (2016) Robert Esterberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
- (2016) Meenakshi Hegde et al. JOURNAL OF CLINICAL INVESTIGATION
- Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells
- (2016) Chengke Luo et al. Oncotarget
- Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
- (2016) Tania Løve Aaes et al. Cell Reports
- Targeting HER2 in the treatment of non-small cell lung cancer
- (2015) Nataliya Mar et al. LUNG CANCER
- The diverse role of RIP kinases in necroptosis and inflammation
- (2015) John Silke et al. NATURE IMMUNOLOGY
- Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
- (2015) Cindy L. Schwartz et al. PEDIATRIC BLOOD & CANCER
- HER2/ERBB2 immunoreactivity in human retinoblastoma
- (2015) G. M. Seigel et al. TUMOR BIOLOGY
- HER2 as a novel therapeutic target for cervical cancer
- (2015) Doo-Yi Oh et al. Oncotarget
- Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via “differentiation-based nano-therapy”
- (2015) Marco Fiorillo et al. Oncotarget
- Immunotherapy of Childhood Sarcomas
- (2015) Stephen S. Roberts et al. Frontiers in Oncology
- SnapShot: Necroptosis
- (2014) Wen Zhou et al. CELL
- HER2 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
- (2014) Netanya I. Pollock et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms of chemoresistance in osteosarcoma (Review)
- (2014) HONGTAO HE et al. Oncology Letters
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Graphene-based nanomaterials for drug delivery and tissue engineering
- (2013) Sumit Goenka et al. JOURNAL OF CONTROLLED RELEASE
- Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
- (2012) J Harder et al. BRITISH JOURNAL OF CANCER
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
- (2012) Liming Sun et al. CELL
- The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis
- (2012) Jixi Li et al. CELL
- Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
- (2012) David Ebb et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibacterial Activity of Graphite, Graphite Oxide, Graphene Oxide, and Reduced Graphene Oxide: Membrane and Oxidative Stress
- (2011) Shaobin Liu et al. ACS Nano
- cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
- (2011) Maria Feoktistova et al. MOLECULAR CELL
- Phosphorylation of Caspase-8 (Thr-263) by Ribosomal S6 Kinase 2 (RSK2) Mediates Caspase-8 Ubiquitination and Stability
- (2010) Cong Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
- (2009) Nabil Ahmed et al. MOLECULAR THERAPY
- Her2 activates NF-κB and induces invasion through the canonical pathway involving IKKα
- (2009) E C Merkhofer et al. ONCOGENE
- A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer
- (2009) Andre Mihaljevic et al. BMC Surgery
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Specific Tyrosine Kinase Inhibitors Regulate Human Osteosarcoma Cells In vitro
- (2008) Patrick J. Messerschmitt et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Nano-graphene oxide for cellular imaging and drug delivery
- (2008) Xiaoming Sun et al. Nano Research
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
- Gene amplification and overexpression of HER2 in renal cell carcinoma
- (2004) Z. Latif et al. BJU INTERNATIONAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started